By Puyaan Singh Sept 23 (Reuters) – Basecamp Research said on Wednesday it has raised $140 million in a Series C funding round that valued the AI-based drug developer at $800 million. The
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
VIDEO SHOWS: HIGHLIGHTS OF PHILADELPHIA PHILLIES V MILWAUKEE BREWERS MLB GAME COMPLETE SHOTLIST TO FOLLOW …
By Greta Rosen Fondahn and Helen Reid STOCKHOLM, Sept 24 (Reuters) - Swedish fashion retailer…
By Renju Jose and Chris Thomas SYDNEY, Sept 24 (Reuters) - Australia said on Thursday…
Sept 24 (Reuters) - RAYA HOLDING FOR FINANCIAL INVESTMENT: * RAYA HOLDING - BOARD CONDITIONALLY…
VIDEO SHOWS: HIGHLIGHTS FROM THE LOS ANGELES DODGERS V THE SAN DIEGO PADRES IN THE…
KYIV, Sept 24 (Reuters) - Ukraine exported 0.96 million metric tons of grain over September…